N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine

C92H99N35O4 — CID 162263194

IUPACN-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine
SMILESCCC(=O)N(C)Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12.CCN(Cc1nc2c(N)nc3cc(-c4ccn[nH]4)ccc3c2n1C)C(C)=O.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(=O)C(C)C.CN(C)Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12.CN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(=O)C1CC1
InChIInChI=1S/C20H23N7O.C19H19N7O.C19H21N7O.C18H19N7O.C16H17N7/c1-4-27(20(28)11(2)3)10-16-24-17-13-6-5-12(14-7-8-22-26-14)9-15(13)23-19(21)18(17)25-16;1-26(19(27)10-2-3-10)9-15-23-16-12-5-4-11(13-6-7-21-25-13)8-14(12)22-18(20)17(16)24-15;1-4-26(11(2)27)10-16-23-17-18(25(16)3)13-6-5-12(14-7-8-21-24-14)9-15(13)22-19(17)20;1-3-15(26)25(2)9-14-22-16-11-5-4-10(12-6-7-20-24-12)8-13(11)21-18(19)17(16)23-14;1-23(2)8-13-20-14-10-4-3-9(11-5-6-18-22-11)7-12(10)19-16(17)15(14)21-13/h5-9,11H,4,10H2,1-3H3,(H2,21,23)(H,22,26)(H,24,25);4-8,10H,2-3,9H2,1H3,(H2,20,22)(H,21,25)(H,23,24);5-9H,4,10H2,1-3H3,(H2,20,22)(H,21,24);4-8H,3,9H2,1-2H3,(H2,19,21)(H,20,24)(H,22,23);3-7H,8H2,1-2H3,(H2,17,19)(H,18,22)(H,20,21)
InChIKeyZZNPWNIGRHYODY-UHFFFAOYSA-N
MW1759.04 g/mol
LogP12.60
Rot. Bonds20

About N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine

N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine (PubChem CID 162263194) has the molecular formula C92H99N35O4 and a molecular weight of 1759.04 g/mol. Its IUPAC name is N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine.

Molecular Properties

Compound NameN-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine
PubChem CID162263194
Molecular FormulaC92H99N35O4
Molecular Weight1759.04 g/mol
Exact Mass1757.86
IUPAC NameN-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine
SMILESCCC(=O)N(C)Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12.CCN(Cc1nc2c(N)nc3cc(-c4ccn[nH]4)ccc3c2n1C)C(C)=O.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(=O)C(C)C.CN(C)Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12.CN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(=O)C1CC1
InChIInChI=1S/C20H23N7O.C19H19N7O.C19H21N7O.C18H19N7O.C16H17N7/c1-4-27(20(28)11(2)3)10-16-24-17-13-6-5-12(14-7-8-22-26-14)9-15(13)23-19(21)18(17)25-16;1-26(19(27)10-2-3-10)9-15-23-16-12-5-4-11(13-6-7-21-25-13)8-14(12)22-18(20)17(16)24-15;1-4-26(11(2)27)10-16-23-17-18(25(16)3)13-6-5-12(14-7-8-21-24-14)9-15(13)22-19(17)20;1-3-15(26)25(2)9-14-22-16-11-5-4-10(12-6-7-20-24-12)8-13(11)21-18(19)17(16)23-14;1-23(2)8-13-20-14-10-4-3-9(11-5-6-18-22-11)7-12(10)19-16(17)15(14)21-13/h5-9,11H,4,10H2,1-3H3,(H2,21,23)(H,22,26)(H,24,25);4-8,10H,2-3,9H2,1H3,(H2,20,22)(H,21,25)(H,23,24);5-9H,4,10H2,1-3H3,(H2,20,22)(H,21,24);4-8H,3,9H2,1-2H3,(H2,19,21)(H,20,24)(H,22,23);3-7H,8H2,1-2H3,(H2,17,19)(H,18,22)(H,20,21)
InChIKeyZZNPWNIGRHYODY-UHFFFAOYSA-N
XLogP12.60
TPSA554.97 Ų
H-Bond Donors14
H-Bond Acceptors26
Rotatable Bonds20
Heavy Atoms131
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001759.04
LogP ≤ 512.60
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1026

Analyze N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine?
The IUPAC name of N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine (CID 162263194) is N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine.
What is the SMILES notation for N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine?
The canonical SMILES for N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine is CCC(=O)N(C)Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12.CCN(Cc1nc2c(N)nc3cc(-c4ccn[nH]4)ccc3c2n1C)C(C)=O.CCN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(=O)C(C)C.CN(C)Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12.CN(Cc1nc2c([nH]1)c(N)nc1cc(-c3ccn[nH]3)ccc12)C(=O)C1CC1.
What is the InChIKey of N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine?
The InChIKey is ZZNPWNIGRHYODY-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H23N7O.C19H19N7O.C19H21N7O.C18H19N7O.C16H17N7/c1-4-27(20(28)11(2)3)10-16-24-17-13-6-5-12(14-7-8-22-26-14)9-15(13)23-19(21)18(17)25-16;1-26(19(27)10-2-3-10)9-15-23-16-12-5-4-11(13-6-7-21-25-13)8-14(12)22-18(20)17(16)24-15;1-4-26(11(2)27)10-16-23-17-18(25(16)3)13-6-5-12(14-7-8-21-24-14)9-15(13)22-19(17)20;1-3-15(26)25(2)9-14-22-16-11-5-4-10(12-6-7-20-24-12)8-13(11)21-18(19)17(16)23-14;1-23(2)8-13-20-14-10-4-3-9(11-5-6-18-22-11)7-12(10)19-16(17)15(14)21-13/h5-9,11H,4,10H2,1-3H3,(H2,21,23)(H,22,26)(H,24,25);4-8,10H,2-3,9H2,1H3,(H2,20,22)(H,21,25)(H,23,24);5-9H,4,10H2,1-3H3,(H2,20,22)(H,21,24);4-8H,3,9H2,1-2H3,(H2,19,21)(H,20,24)(H,22,23);3-7H,8H2,1-2H3,(H2,17,19)(H,18,22)(H,20,21).
What are the key properties of N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine?
N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine has a molecular weight of 1759.04 g/mol, XLogP of 12.60, 20 rotatable bonds, 14 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-amino-1-methyl-7-(1H-pyrazol-5-yl)imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethyl-2-methylpropanamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylcyclopropanecarboxamide;N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-methylpropanamide;2-[(dimethylamino)methyl]-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-4-amine is sourced from PubChem (CID 162263194), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).